Clinical Trials on Arterial Coronary Disease

Total 381642 results

Biotronik, Inc.

Completed

BIOHELIX-I Bare Metal Stent Study (BIOHELIX-I)

Coronary Arteries Disease

United States, Netherlands, Latvia, Colombia, Germany
Seung-Jung Park
CardioVascular Research Foundation, Korea

Completed

Ten-Year Outcomes of Stents Versus Coronary-Artery Bypass Grafting for Left Main Coronary Artery Disease (MAIN COMPARE)

Coronary Arteries

Korea, Republic of
Meshalkin Research Institute of Pathology of Circulation

Unknown

The Assessment of Progression of Paroxysmal AF After CABG

Paroxysmal Atrial Fibrillation, Coronary Artery Disease

Russian Federation
Air Liquide Santé International
Eurofins Biomnis; MONITORING FORCE GROUP CROs; Inferential

Completed

Cardiovascular Safety of Xenon in General Anaesthesia, in Patient With Cardiovascular Risk in Non Cardiac Surgery (CARVASAXe)

Elevated Cardiac Risk | Coronary Arteries Disease Risk

France
TCA Cellular Therapy

Suspended

Phase II Combination Stem Cell Therapy for the Treatment of Severe Coronary Ischemia(CI)

Coronary Artery Disease | Coronary Disease | Heart Disease | Coronary Atherosclerosis | Coronary Ischemia | Blocked Arteries

United States
Cairo University

Recruiting

Once Versus Twice Bisoprolol Dosage Regimen in Prevention of Atrial Fibrillation Post Coronary Artery Bypass Graft Surgery

Coronary Artery Disease | Postoperative Atrial Fibrillation | Coronary Artery Bypass Grafting

Egypt
University of Florida
Janssen Scientific Affairs, LLC

Completed

Pharmacodynamic Effects of Low-dose Rivaroxaban With Antiplatelet Therapies

Coronary Artery Disease | Peripheral Arterial Disease | Atrial Fibrillation

United States
Meshalkin Research Institute of Pathology of Circulation

Unknown

Surgical Ablation of Long-standing Persistent AF During CABG (LABARFA)

Coronary Artery Disease

Russian Federation
Cardiovascular Innovation and Research Institute
Valley View Hospital

Recruiting

Cardiovascular Innovation & Research Institute 's NEXUS Registry, the Whole is Greater Than the Parts.

Coronary Artery Disease | Atrial Fibrillation (AF)

United States
AstraZeneca

Completed

Exploratory Study of Coronary Flow Reserve Measurements, a Non-Invasive Method for Coronary Function Measurements

Atherosclerosis | Inflammatory Activity in Coronary Arteries

Sweden
Abbott Medical Devices

Terminated

A(f)MAZE-CABG Study (AFMAZE-CABG)

Atrial Fibrillation | Coronary Arteriosclerosis | Coronary Artery Bypass Graft Surgery

Canada, United Kingdom, Netherlands, Norway, Finland, Germany
Icahn School of Medicine at Mount Sinai
Bristol-Myers Squibb

Completed

Antithrombotic Strategy Variability In ATrial Fibrillation and Obstructive Coronary Disease Revascularized With PCI - The AVIATOR 2 Registry

Non-valvular Atrial Fibrillation

United States
Kun Hua

Active, not recruiting

Predictors of Postoperative Atrial Fibrillation After CABG (CODA-AF)

Coronary Artery Disease | Atrial Fibrillation New Onset

China
Hippocration General Hospital
Win Medica; Pharmassist Ltd

Recruiting

Flecainide Versus Amiodarone in the Cardioversion of Paroxysmal Atrial Fibrillation at the Emergency Department, in Patients With Coronary Artery Disease Without Residual Ischemia (FLECA-ED)

Atrial Fibrillation Paroxysmal | Coronary Artery Disease Without Residual Ischemia

Greece
Henan Institute of Cardiovascular Epidemiology

Unknown

Effect of Antithrombotic Treatment in Patients With Both Coronary Heart Disease and Atrial Fibrillation (ACHDAF)

Atrial Fibrillation | Coronary Heart Disease

China
Neuromed IRCCS

Terminated

Supplementation With Polyphenol-Rich Foods and Atrial Fibrillation After a Cardiac Surgery (Polyphemus)

Coronary Heart Disease

Italy
Cardiovascular Research Center, Brazil

Completed

Brazil Xience V Everolimus-Eluting Coronary Stent System "Real-World" Outcomes Registry (BRAVO)

Arterial Coronary Disease

Brazil
Deutsches Herzzentrum Muenchen

Terminated

Impact of Dabigatran and Phenprocoumon on Clopidogrel Mediated ADP Induced Platelet Aggregation in Patients With Atrial Fibrillation (Dabi-ADP-2)

Atherosclerosis | Atrial Fibrillation | Coronary Heart Disease | Acute Coronary Syndrome

Germany
Seoul National University Hospital

Recruiting

Effect of Left Posterior Pericardiotomy for the Prevention of POAF (ELIMINATE-AF)

Coronary Artery Disease | Pericardial Effusion | Atrial Fibrillation New Onset

Korea, Republic of
Central Hospital, Nancy, France

Unknown

The Impact of Video Information on Preoperative Anxiety in Interventional Cardiology Patients. (VATIC)

Coronary Artery Disease | Atrial Fibrillation | Atrial Flutter
Yuejiang Liu

Completed

Validity Study of Glutamine to Improve Cardiac Function in Cardiac Surgery

Coronary Heart Disease | Rheumatic Heart Disease

China
Zhejiang Hisun Pharmaceutical Co. Ltd.

Completed

Efficacy and Safety Study of the HS-25 Combination With Atorvastatin in Subjects With Hypercholesterolemia in Coronary Heart Diseases (HS-25-III-02)

Hypercholesterolemia in Coronaory Heart Disease
R&D Cardiologie
St. Antonius Hospital

Unknown

What is the Optimal antiplatElet and Anticoagulant Therapy in Patients With Oral Anticoagulation Undergoing revasculariSaTion 2. (WOEST 2)

Myocardial Infarction | Stroke | Bleeding | Acute Coronary Syndromes | Coronary Artery Diseases | Atrial Fibrillations | Heart Valve Prostheses

Belgium, Netherlands
Medical Care Center Prof. Mathey, Prof. Schofer...
Abbott Medical Devices

Completed

ABSORB: Postmarketing Surveillance Registry to Monitor the Everolimus-eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease (ASSURE)

Myocardial Ischemia | Heart Diseases | Cardiovascular Diseases | Vascular Diseases | Coronary Artery Disease | Coronary Disease | Arteriosclerosis | Arterial Occlusive Diseases | Coronary Stenosis | Coronary Restenosis

Germany
Medical Care Center Prof. Mathey, Prof. Schofer...

Unknown

The ASSURE ROT Registry: Bioresorbable Vascular Scaffold Following Rotablation for Complex Coronary Lesions (ASSURE ROT)

Myocardial Ischemia | Heart Diseases | Cardiovascular Diseases | Vascular Diseases | Coronary Artery Disease | Coronary Disease | Arteriosclerosis | Arterial Occlusive Diseases | Coronary Stenosis | Coronary Restenosis

Germany
LMU Klinikum
University Medicine Greifswald; Technical University of Munich; Helmholtz Zentrum... and other collaborators

Completed

APixaban vs. PhenpRocoumon in Patients With ACS and AF: APPROACH-ACS-AF (APPROACH)

Coronary Artery Disease | Atrial Fibrillation | Acute Coronary Syndrome

Germany
University of Campania "Luigi Vanvitelli"

Completed

DNA Methylation Analysis in Acute Coronary Syndrome and Atrial Fibrillation: DIANA Clinical Trial

Coronary Artery Disease | Atrial Fibrillation | Acute Coronary Syndrome

Italy
Brigham and Women's Hospital
Jichi Medical University; Shin Koga Hospital; Kokura Memorial Hospital; Shonan... and other collaborators

Unknown

Prediction of Progression of Coronary Artery Disease (CAD) Using Vascular Profiling of Shear Stress and Wall Morphology (PREDICTION)

Acute Coronary Syndrome | Percutaneous Coronary Intervention | Coronary Atherosclerosis | Endothelial Shear Stress | Arterial Remodeling

United States
Spectrum Health Hospitals

Completed

Prophylactic Maze to Prevent Atrial Fibrillation in Adult Cardiac Surgery (PREVENT-AF)

Coronary Artery Disease

United States
Korea University Anam Hospital
Ulsan University Hospital; Gachon University Gil Medical Center; Severance Hospital and other collaborators

Completed

LAAO With DAPT Versus Antithrombotic Therapy

Coronary Artery Disease | Atrial Fibrillation
Deutsches Herzzentrum Muenchen

Unknown

Triple Therapy in Patients on Oral Anticoagulation After Drug Eluting Stent Implantation (ISAR-TRIPLE)

Coronary Artery Disease | Atrial Fibrillation

Denmark, Germany
Beijing Anzhen Hospital

Unknown

Rivaroxaban in Patients With Atrial Fibrillation and Coronary Artery Disease Undergoing Percutaneous Coronary Intervention

Atrial Fibrillation

China
J.P.S Henriques

Not yet recruiting

Rivaroxaban Monotherapy After CYP2C19 Genotype Testing in Patients With Atrial Fibrillation and Percutaneous Coronary Intervention (IMPACT AF-PCI)

Coronary Artery Disease | Atrial Fibrillation
Basaksehir Cam & Sakura Şehir Hospital

Recruiting

Postoperative Lactate and Atrial Fibrillation After CABG

Coronary Artery Disease | Atrial Fibrillation

Turkey
Bursa Postgraduate Hospital

Completed

Rivaroxaban - Percutaneous Coronary Intervention

Coronary Artery Disease | Atrial Fibrillation

Turkey
Attikon Hospital
Hellenic Cardiology Society

Completed

The Greek AntiPlatElet Atrial Fibrillation Registry. (GRAPE-AF)

Coronary Artery Disease | Atrial Fibrillation

Greece
Shenyang Northern Hospital
Beijing Anzhen Hospital; Second Affiliated Hospital of Third Military Medical...

Unknown

Dabigatran Versus Warfarin With NVAF Who Undergo PCI (COACH-AF-PCI)

Coronary Artery Disease | Atrial Fibrillation

China
Meshalkin Research Institute of Pathology of Circulation

Unknown

TEmporary Spinal CoRd StiMulatIon to PrevenNt Atrial FibrillaTION AFter Cardiac Surgery (TerminationAF)

Coronary Artery Disease | Atrial Fibrillation

Russian Federation
University of Utah

Completed

Regadenoson Stress-MRI to Identify Coronary Artery Disease in Atrial Fibrillation Patients (RECAD-AF)

Coronary Artery Disease | Atrial Fibrillation

United States
Japan Cardiovascular Research Foundation

Unknown

Atrial Fibrillation and Ischemic Events With Rivaroxaban in Patients With Stable Coronary Artery Disease Study (AFIRE)

Atrial Fibrillation

Japan
University Hospital, Brest
Bayer

Recruiting

Assessment of Quitting Versus Using Aspirin Therapy In Patients Treated With Oral Anticoagulation for Atrial Fibrillation or Other Indication With Stabilized Coronary Artery Disease (AQUATIC)

Coronary Artery Disease

France
Boehringer Ingelheim

Completed

A Study Based on Japanese Medical Records That Looks at Bleeding Events in People With Atrial Fibrillation and Coronary Artery Disease Who Start Taking Either Dabigatran, Rivaroxaban, or Warfarin

Coronary Artery Disease | Atrial Fibrillation

Germany
Genshan Ma
Zhongda Hospital

Completed

Safety of "Ticagrelor+ Warfarin"in Comparison With "Clopidogrel+Aspirin+Warfarin"

Coronary Artery Disease | Atrial Fibrillation

China
Yonsei University

Terminated

Safety and Efficacy of Left Atrial Appendage Closure Versus Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Drug-Eluting Stent Implantation Due to Complex Coronary Artery Disease

Coronary Artery Disease | Atrial Fibrillation

Korea, Republic of
Satoshi Shizuta
Daiichi Sankyo Co., Ltd.; Research Institute for Production Development

Completed

Optimizing Antithrombotic Care in Patients With AtriaL fibrillatiON and Coronary stEnt (OAC-ALONE) Study (OAC-ALONE)

Coronary Artery Disease | Atrial Fibrillation

Japan
Medtronic Bakken Research Center
Medtronic

Terminated

Clinical and Economic Consequences of Left Atrial Bipolar Radiofrequency Ablation of Persistent and Permanent Atrial Fibrillation During Cardiac Surgery

Coronary Artery Disease | Atrial Fibrillation

Germany
Servier Russia

Completed

Assessment of the Efficacy and Tolerability of the Fixed-dose Combination of Bisoprolol/Perindopril (STYLE)

Arterial Hypertension | CHD - Coronary Heart Disease

Russian Federation
General Hospital of Shenyang Military Region

Completed

Relationship Between Apelin and New-onset Atrial Fibrillation After Coronary Artery Bypass Grafting

Coronary Atherosclerotic Heart Disease
Zuyderland Medisch Centrum

Not yet recruiting

Comparison Between Direct Oral Anticoagulation (DOAC) Interruption and DOAC Continuation in Patients Undergoing Elective Invasive Coronary Angiography or Percutaneous Coronary Intervention (SLIM-2)

Coronary Artery Disease | Atrial Fibrillation | Anticoagulants
Kuopio University Hospital

Terminated

Surgical Pulmonary Vein Isolation Efficiency Study (FIN-PVI)

Coronary Artery Disease | Paroxysmal Atrial Fibrillation

Finland

Clinical Trials on Arterial Coronary Disease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Japan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations